Efficacy of Acupuncture Treatment to Prevent Cerebral Vasospasm After Subarachnoid Hemorrhage: A Double-Blind, Randomized Placebo-Controlled Trial

被引:9
|
作者
Lee, Dong-Hyuk [1 ]
Cho, Seung-Yeon [1 ,2 ]
Yang, Seung-Bo [1 ,2 ]
Lee, Hyoung-Min [3 ]
Shin, Hee Sup [2 ,4 ]
Lee, Seung Hwan [2 ,4 ]
Koh, Jun Seok [2 ,4 ]
Kwon, Seungwon [1 ]
Jung, Woo-Sang [1 ]
Moon, Sang-Kwan [1 ]
Park, Jung-Mi [1 ,2 ]
Ko, Chang-Nam [1 ,2 ]
Kim, Ho [5 ,6 ]
Park, Seong-Uk [1 ,2 ]
机构
[1] Kyung Hee Univ, Dept Cardiol & Neurol, Coll Korean Med, Seoul, South Korea
[2] Kyung Hee Univ Hosp Gangdong, Stroke & Neurol Disorders Ctr, 892 Dongnam Ro, Seoul 05278, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Clin Korean Med, Seoul, South Korea
[4] Kyung Hee Univ, Sch Med, Dept Neurosurg, Seoul, South Korea
[5] Seoul Natl Univ, Dept Epidemiol & Biostat, Grad Sch Publ Hlth, Seoul, South Korea
[6] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea
关键词
cerebral vasospasm; delayed ischemic neurologic deficit (DIND); SAH; acupuncture; electroacupuncture; NITRIC-OXIDE; PLASMA ENDOTHELIN; ELECTROACUPUNCTURE; HYPERTENSION; MECHANISMS; STROKE;
D O I
10.1089/acm.2020.0156
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives:To investigate the efficacy of acupuncture in preventing cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) and explore its underlying mechanism. Design:A randomized, double-blinded, and placebo-controlled trial. Setting/Location:Subjects were recruited from Kyung Hee University Hospital at Gangdong, Seoul, Korea Subjects:A total of 50 patients admitted with acute SAH. Interventions:The study group received acupuncture treatments (n = 25), while the control group underwent mock transcutaneous electrical nerve stimulation and sham acupuncture (n = 25) six times/week for 2 weeks. Outcome measures:The primary outcome was the incidence of delayed ischemic neurologic deficit (DIND), and secondary measurements included angiographic vasospasm, vasospasm-related infarction, modified Rankin Scale score, and plasma nitric oxide (NO) and endothelin-1 (ET-1) levels. Results:The study group treated with acupuncture showed a lower incidence of DIND (9.1%) than the control group (20.8%); however, this difference in the incidence of DIND was not statistically significant. The study group demonstrated better clinical outcomes, especially in functional recovery. Significant alterations in plasma NO and ET-1 levels after the 2-week intervention were observed only in the study group. Conclusions:Their study shows that acupuncture treatment improved functional recovery after SAH and could potentially prevent cerebral vasospasm. These effects could be attributed to the recovery of endothelial dysfunction by acupuncture through modulating the plasma NO and ET-1 levels. The study protocol has been registered onwww.clinicaltrials.gov(NCT02275949).
引用
收藏
页码:1182 / 1189
页数:8
相关论文
共 50 条
  • [31] Acupuncture for Japanese Katakori (Chronic Neck Pain): A Randomized Placebo-Controlled Double-Blind Study
    Takakura, Nobuari
    Takayama, Miho
    Kawase, Akiko
    Kaptchuk, Ted J.
    Kong, Jian
    Vangel, Mark
    Yajima, Hiroyoshi
    MEDICINA-LITHUANIA, 2023, 59 (12):
  • [32] Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial
    Hendouei, Fatemeh
    Moghaddam, Hossein Sanjari
    Mohammadi, Mohammad Reza
    Taslimi, Negin
    Rezaei, Farzin
    Akhondzadeh, Shahin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (02) : 324 - 334
  • [33] Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial
    Juan Manuel Marquez-Romero
    Antonio Arauz
    José Luis Ruiz-Sandoval
    Erick de la Cruz-Estrada
    Maria Raquel Huerta-Franco
    Gerónimo Aguayo-Leytte
    Angélica Ruiz-Franco
    Humberto Silos
    Trials, 14
  • [34] Efficacy of acupuncture for endometriosis-associated pain: a multicenter randomized single-blind placebo-controlled trial
    Li, Pei Shuang
    Peng, Xue Mei
    Niu, Xiang Xin
    Xu, Ling
    Ng, Ernest Hung Yu
    Wang, Chi Chiu
    Dai, Jin Fang
    Lu, Jun
    Liang, Rui Ning
    FERTILITY AND STERILITY, 2023, 119 (05) : 815 - 823
  • [35] Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial
    Manuel Marquez-Romero, Juan
    Arauz, Antonio
    Luis Ruiz-Sandoval, Jose
    de la Cruz-Estrada, Erick
    Raquel Huerta-Franco, Maria
    Aguayo-Leytte, Geronimo
    Ruiz-Franco, Angelica
    Silos, Humberto
    TRIALS, 2013, 14
  • [36] Lack of Efficacy of Dextromethorphan in Managing Alcohol Withdrawal A Preliminary Report of a Randomized, Double-Blind, Placebo-Controlled Trial
    Huang, Ming-Chyi
    Chen, Chun-Hsin
    Pan, Chun-Hung
    Lin, Shih-Ku
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 149 - 152
  • [37] Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
    Sun, Yuanlong
    Hu, Na
    Chen, Gaofeng
    Wang, Yanjie
    Hu, Yiyang
    Ge, Maojun
    Zhao, Yu
    TRIALS, 2022, 23 (01)
  • [38] Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
    Kim, Kwang-Min
    Kim, Moon-Jong
    Song, Sang-Wook
    Cho, Doo-Yeoun
    Park, Kyung-Chae
    Yang, Sung-Won
    Kim, Young-Sang
    Kim, Kyung-Soo
    CHINESE MEDICAL JOURNAL, 2016, 129 (02) : 129 - 134
  • [39] A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy
    Starkstein, Sergio E.
    Brockman, Simone
    Hatch, Katherine K.
    Bruce, David G.
    Almeida, Osvaldo P.
    Davis, Wendy A.
    Robinson, Robert G.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05) : 1119 - 1127
  • [40] A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder
    Brown, E. Sherwood
    Van Enkevort, Erin
    Kulikova, Alexandra
    Escalante, Chastity
    Nakamura, Alyson
    Ivleva, Elena I.
    Holmes, Traci
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02): : 317 - 323